Financials

  • Market Capitalization 8.54 B
  • Employee 691
  • Founded 2014
  • CEO Rich Adcock
  • Website www.immunitybio.com
  • Headquarter Delaware, United States
  • FIGI BBG007T9DYW9
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-5.21
市销率
16.08

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
995
ABVX
Abivax SA - American Depositary Shares
113.37 USD-0.81%-1.37%-9.23%+38.26%8.90 B USD
1009
IMVT
Immunovant, Inc. - Common Stock
41.19 USD-6.00%-7.17%+5.67%+114.42%8.51 B USD
1022
APGE
Apogee Therapeutics, Inc. - Common Stock
134.97 USD+0.01%+0.16%+0.61%+151.86%8.40 B USD
1031
TGTX
TG Therapeutics, Inc. - Common Stock
53.92 USD-3.23%-0.64%-1.73%+85.80%8.25 B USD

新闻